APPLICATION
BLA761424
TYPE
BLA
ORIGINAL APPROVAL
2025-10-29
LATEST ACTION
2025-10-29
ROUTE
SUBCUTANEOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
OSVYRTIPrescription
denosumab-desu 60MG/ML · INJECTABLE · SUBCUTANEOUS
JUBEREQPrescription
denosumab-desu 120MG/1.7ML · INJECTABLE · SUBCUTANEOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.